NL161759B - Werkwijze ter bereiding van salicylzuurverbindingen, werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen. - Google Patents

Werkwijze ter bereiding van salicylzuurverbindingen, werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.

Info

Publication number
NL161759B
NL161759B NL6813639.A NL6813639A NL161759B NL 161759 B NL161759 B NL 161759B NL 6813639 A NL6813639 A NL 6813639A NL 161759 B NL161759 B NL 161759B
Authority
NL
Netherlands
Prior art keywords
preparation
salicylic acid
pharmaceutical preparations
acid compounds
properties obtained
Prior art date
Application number
NL6813639.A
Other languages
English (en)
Other versions
NL6813639A (nl
NL161759C (nl
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NL6813639A publication Critical patent/NL6813639A/xx
Publication of NL161759B publication Critical patent/NL161759B/nl
Application granted granted Critical
Publication of NL161759C publication Critical patent/NL161759C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL6813639.A 1967-10-06 1968-09-24 Werkwijze ter bereiding van salicylzuurverbindingen, werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen. NL161759C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67327367A 1967-10-06 1967-10-06

Publications (3)

Publication Number Publication Date
NL6813639A NL6813639A (nl) 1969-04-09
NL161759B true NL161759B (nl) 1979-10-15
NL161759C NL161759C (nl) 1980-03-17

Family

ID=24701969

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6813639.A NL161759C (nl) 1967-10-06 1968-09-24 Werkwijze ter bereiding van salicylzuurverbindingen, werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.

Country Status (7)

Country Link
US (1) US3558641A (nl)
BR (1) BR6802728D0 (nl)
CH (1) CH502981A (nl)
DE (1) DE1801303A1 (nl)
FR (1) FR1585315A (nl)
GB (1) GB1214079A (nl)
NL (1) NL161759C (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993763A (en) * 1969-03-18 1976-11-23 Ciba-Geigy Corporation Tertiary aminoacids as anti-inflammatory agents
US4001420A (en) * 1968-12-12 1977-01-04 Science Union Et Cie, Societe Francaise De Recherche Medical Thiazolyl benzoic acid compounds
US3682968A (en) * 1969-06-25 1972-08-08 Merck & Co Inc Anti-inflammatory salicylic acid derivatives
US3676451A (en) * 1970-06-09 1972-07-11 Merck & Co Inc Thiazolylsalicylic acids
GB1308028A (en) * 1970-06-12 1973-02-21 Science Union & Cie Thiazolylbenzoic acid derivatives and a process for their manufactur
US3687971A (en) * 1970-06-22 1972-08-29 Merck & Co Inc 4-(pyrrolyl)-salicylic acid derivatives
US3929833A (en) * 1970-10-30 1975-12-30 Sandoz Ag Organic compounds
FR2128285A1 (en) * 1971-03-11 1972-10-20 Berlin Chemie Veb Imidazole derivs - with hypotensive mao-inhibitory, anticonvulsant antiinflammatory choleretic and antiviral activity prepn
FR2128292A1 (en) * 1971-03-12 1972-10-20 Berlin Chemie Veb Imidazole derivs - with hypotensive, mao-inhibitory, anticonvulsant antiinflammatory, choleretic and antiviral activity prepn
US3860640A (en) * 1972-04-12 1975-01-14 Nippon Shinyaku Co Ltd 3-alkoxy-5-substituted phenylacetic acids
US3865839A (en) * 1973-03-01 1975-02-11 Hoechst Co American Thiopyranopyrrolylsalicyclic acids and derivatives thereof
US4111935A (en) * 1975-01-02 1978-09-05 Smith Kline & French Laboratories Limited 3-chloro-6-phenylpyridazine compounds
US4152341A (en) * 1975-12-29 1979-05-01 Imperial Chemical Industries Limited Triaryl or diarylpyridyl methanes
GB1560880A (en) * 1975-12-29 1980-02-13 Ici Ltd Diphenylmethane derivatives and pharmaceutical compositions containing them
DE2818765A1 (de) * 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
DE3668450D1 (de) * 1985-03-14 1990-03-01 Smithkline Dauelsberg 5-aminosalicylsaeurederivate von nicht-steroidalen entzuendungshemmenden sauren.
GB9204808D0 (en) * 1992-03-04 1992-04-15 Rhone Poulenc Rorer Ltd Novel compositions of matter
ES2639863B1 (es) * 2017-03-10 2018-09-20 Universidad De Granada Compuestos para el tratamiento de enfermedades causadas por la acumulación de oxalato

Also Published As

Publication number Publication date
NL6813639A (nl) 1969-04-09
DE1801303A1 (de) 1969-06-19
FR1585315A (nl) 1970-01-16
CH502981A (de) 1971-02-15
BR6802728D0 (pt) 1973-05-10
US3558641A (en) 1971-01-26
NL161759C (nl) 1980-03-17
GB1214079A (en) 1970-12-02

Similar Documents

Publication Publication Date Title
NL146485B (nl) Werkwijze ter bereiding van 3-benzoylfenylazijnzuurderivaten bevattende farmaceutische preparaten met een anti-inflammatoire werking en gevormde preparaten verkregen onder toepassing van deze werkwijze.
NL7706646A (nl) Werkwijze ter bereiding van diuretisch werkzame farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, als- mede werkwijze ter bereiding van diuretisch werk- zame verbindingen.
NL161759B (nl) Werkwijze ter bereiding van salicylzuurverbindingen, werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.
NL157192B (nl) Werkwijze ter bereiding van herbicide preparaten.
FI48727C (fi) Menetelmä asetyyliguanidiinien valmistamiseksi.
NL160485C (nl) Werkwijze ter bereiding van farmaceutische preparaten met anti-inflammatoire, analgetische en anti-pyretische wer- king, alsmede door toepassing van deze werkwijze verkregen voorwerpen.
NL155291B (nl) Werkwijze ter bereiding van tegen invloed van warmte gestabiliseerde, vormbare samenstellingen.
NL144944B (nl) Werkwijze voor de bereiding van 6-aminopenicillaanzuurderivaten.
NL145456B (nl) Werkwijze ter bereiding van farmaceutische preparaten, die diarreebestrijdende polymeren bevatten.
NL157313B (nl) Werkwijze voor de bereiding van daunorubicinederivaten met antitumoreigenschappen, alsmede van farmaceutische preparaten, die deze verbindingen bevatten.
NL166917C (nl) Werkwijze ter bereiding van 2.5-dibroomtereftaalzuur.
NL158386B (nl) Werkwijze ter bereiding van farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van farmacologisch werkzame 1h-1,5-benzodiazepine-2,4-dionderivaten.
NL148037B (nl) Werkwijze voor de bereiding van farmaceutische preparaten en de door toepassing daarvan vervaardigde voorwerpen, alsmede werkwijze ter bereiding van anti-inflammatoir, analgetisch, antipyretisch en antipruritisch werkzame verbindingen.
NL7512107A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten met antiinflammatoire werking, de door toepassing daarvan verkregen voorwerpen, alsmede werkwijze ter bereiding van verbindingen met anti-inflammatoire werking.
NL150798B (nl) Werkwijze voor de bereiding van 7-aminocefalosoranzuur en derivaten daarvan.
NL161137B (nl) Werkwijze ter bereiding van ureum.
NL142949B (nl) Werkwijze ter bereiding van salicylaatderivaten, werkwijze ter bereiding van farmaceutische preparaten, alsmede aldus verkregen gevormde preparaten.
NL150434B (nl) Werkwijze voor de bereiding van ethionzuur.
NL170852C (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van anti-inflammatoir werkzaam p-isoindolinylfenylazijnzuur en van derivaten hiervan.
NL146800B (nl) Werkwijze ter bereiding van n-methylcarbaminezuuresters, alsmede van preparaten, die deze verbindingen bevatten.
NL162079C (nl) Werkwijze voor het bereiden van (cis-1,2-epoxypropaan) fosfonzuurverbindingen; werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.
NL143548B (nl) Werkwijze ter bereiding van alfa-sinensal.
NL165129C (nl) Werkwijze voor de bereiding van titaandioxyde.
NL145217B (nl) Werkwijze voor de bereiding van mengsels van in hoofdzaak epsilon-hydroxycapronzuur.
NL141760B (nl) Werkwijze voor de bereiding van herbicide preparaten.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: MERCK